Chairman and CEO

Baylor Genetics Presents New Data on Clinical and Diagnostic Utility of RNA Sequencing for Rare Disease at the American Society of Human Genetics 2025 Annual Meeting

Baylor Genetics to Showcase Clinical and Diagnostic Utility of Genome Sequencing and Multi-omics Across Rare Disease at the American Society of Human Genetics 2025 Annual Meeting

Baylor Genetics to Showcase the Expanding Role and Clinical Value of Genetic Testing in Pediatric Neurology at the 2025 Child Neurology Society Annual Meeting

Baylor Genetics to Showcase RNA Sequencing Breakthroughs for Rare Disease Diagnosis at 2025 AGBT Precision Health Meeting

Sr. Manager Investor Relations

Baylor Genetics is focused on enhancing investor relations and building shareholder confidence. The Sr. Manager will cultivate relationships with the investment community and support strategic communications and planning efforts within the company.

Sign up with Google

Sign in with Google